Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide [PDF]
, 2001 Background: The sulfonylurea glibenclamide (Glib) abolishes the cardioprotective effect of ischemic preconditioning (IP), presumably by inhibiting mitochondrial KATP channel opening in myocytes. Glimepiride (Glim) is a new sulfonylurea reported to affect
Baxter, G.F. +5 more
core
FORMULATION AND CHARACTERIZATION OF TRANSDERMAL PATCHES OF TOLBUTAMIDE
, 2017 Ms Chetna
openalex +2 more sources
Tolbutamide perifusion of rat islets. Sequential changes in calcium, phosphorus, sodium, potassium, and chlorine in single beta cells. [PDF]
, 1983 R K Kalkhoff +2 more
openalex +1 more source
Effects of oral hypoglycemic agents, gliclazide and tolbutamide, on the cardiovascular system
, 1978 Hiroshi Maekawa +3 more
openalex +2 more sources
Failure of ‘therapeutic’ doses of beta‐adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine. [PDF]
, 1984 John O. Miners +3 more
openalex +1 more source
Chlorpropamide- and tolbutamide-alcohol flushing in non-insulin-dependent diabetes. [PDF]
, 1981 L. Capretti +5 more
openalex +1 more source
Influences of Long-term Tolbutamide Administration on Diabetic Syndrome in Alloxan Rabbits
, 1978 Setsuya Takeuchi +7 more
openalex +2 more sources
Formulation and Evaluation Tolbutamide Liposomes for a Sustained Drug Delivery System
, 2022 Devendra Prajapati +3 more
openalex +2 more sources